Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

122 ta ish

Ish: Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity

  1. Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect

    Chengcheng Feng, Yuting Wang, Jinghua Xu +5

    Maqola202411 iqtibos
    ABI

  2. Disorders of cancer metabolism: The therapeutic potential of cannabinoids

    Dingya Sun, Xin Li, Shengdan Nie +2

    Sharh maqola20229 iqtibos
    ABI

  3. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies

    Ding-Ya Sun, Yijie Hu, Xin Li +3

    Sharh maqola20247 iqtibos
    ABI

  4. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

    Maqola20176 iqtibos
    ABI

  5. Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS/MS and its application in the clinical determination in patients with tumors associated with overactive bladder

    Yutao Lou, Mengting Cheng, Qin Cao +7

    Maqola20235 iqtibos
    ABI

  6. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

    Maqola20175 iqtibos
    ABI

  7. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

    Lukas F. Mager, Regula Burkhard, Nicola Pett +10

    Maqola20204 iqtibos
    ABI

  8. Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

    Nathan D. Mathewson, Robert R. Jenq, Anna V. Mathew +18

    Maqola20163 iqtibos
    ABI

  9. Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target

    Mengwei Zhang, Jinkai Liu, Qiang Xia

    Sharh maqola20233 iqtibos
    ABI

  10. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

    Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel +29

    Maqola20203 iqtibos
    ABI

  11. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

    Diwakar Davar, Amiran Dzutsev, John A. McCulloch +29

    Maqola20213 iqtibos
    ABI

  12. Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

    Bret D. Wallace, Hongwei Wang, Kimberly T. Lane +8

    Maqola20103 iqtibos
    ABI

  13. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère, Marie Vétizou, Nadine Waldschmitt +33

    Maqola20163 iqtibos
    ABI

  14. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

    Ygor Parladore Silva, Andressa Bernardi, Rudimar Luiz Frozza

    Sharh maqola20203 iqtibos
    ABI

  15. Fecal 16S rRNA sequencing and multi-compartment metabolomics revealed gut microbiota and metabolites interactions in APP/PS1 mice

    Xin Cheng, Yejun Tan, Hongli Li +8

    Maqola20223 iqtibos
    ABI

  16. Gut microbiota shapes cancer immunotherapy responses

    Wanting Lei, Kexun Zhou, Ye Lei +2

    Sharh maqola20252 iqtibos
    ABI

  17. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

    Ying Taur, Robert R. Jenq, Miguel‐Angel Perales +12

    Maqola20142 iqtibos
    ABI

  18. Comparative genomics of bacterial and plant folate synthesis and salvage: predictions and validations

    Valérie de Crécy‐Lagard, Basma El Yacoubi, Rocío de la Garza +2

    Maqola20072 iqtibos
    ABI

  19. Effect of polyglutamylation of methotrexate on its accumulation and the development of resistance in the protozoan parasite Leishmania

    Amal El Fadili, Dave Richard, Christoph Kündig +1

    Maqola20032 iqtibos
    ABI

  20. Toll-like Receptors on Hematopoietic Progenitor Cells Stimulate Innate Immune System Replenishment

    Yoshinori Nagai, Karla P. Garrett, Shoichiro Ohta +5

    Maqola20062 iqtibos
    ABI

  21. Tertiary Structure of Thiopurine Methyltransferase from Pseudomonas syringae, a Bacterial Orthologue of a Polymorphic, Drug-metabolizing Enzyme

    Thomas H. Scheuermann, Elias Lolis, Michael E. Hodsdon

    Maqola20032 iqtibos
    ABI

  22. Assessing the Performance of Prediction Models

    Ewout W. Steyerberg, Andrew J. Vickers, Nancy R. Cook +5

    Maqola20092 iqtibos
    ABI

  23. Mechanistic insight into digoxin inactivation by<i>Eggerthella lenta</i>augments our understanding of its pharmacokinetics

    Henry J. Haiser, Kristen L. Seim, Emily P. Balskus +1

    Maqola20142 iqtibos
    ABI

  24. Gut microbiome interactions with drug metabolism, efficacy, and toxicity

    Ian D. Wilson, Jeremy K. Nicholson

    Sharh maqola20162 iqtibos
    ABI

  25. Targeting A2 adenosine receptors in cancer

    David Allard, Martin Turcotte, John Stagg

    Sharh maqola20172 iqtibos
    ABI